AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
INDIANAPOLIS, Feb. 2 /PRNewswire-AsiaNet/ — Proposed projects will combat global diseases Kiwanis International is searching for its next global cause, and its International Board of Trustees has selected three Worldwide Service Project finalists: Global Network for Neglected Tropical Diseases for their Neglected Tropical Diseases (NTDs) proposal; Malaria No More and …
Read More »Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
CALGARY, Feb. 1 /CNW-AsiaNet/ — TSX Exchange Symbol: RVX Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that the Board of Directors has elected Arthur J. Higgins, CEO of Bayer HealthCare and Chairman of the Bayer HealthCare Executive Committee, to the Board effective February 1, 2010. Mr. Higgins joined …
Read More »UBM Sees Significant Rise in Interest in 2009 for Indian Pharma Shows
MAARSEN, Jan. 20 /PRNewswire-AsiaNet/ — 20% increases in exhibitors, coupled with 5% rise in attendees, reflects continued growth in region’s Pharmaceutical industry Reflecting the continued growth in the fine chemicals, pharmaceuticals and bio-pharmaceuticals industries on the Indian sub-continent, leading events organisers UBM International Media and its sister company UBM India …
Read More »اوکٹافارما نے ون ولیبرانڈ بیماری کے لیے خاص طور پر تیار کردہ پہلے ری پلیس منٹ طریقہ علاج ولیٹ (ر) کے لیے اورفن ڈرگ کی امتیازی منظوری حاصل کر لی
لاخن، سوئٹزرلینڈ، 13 جنوری/پی آرنیوزوائر-ایشیانیٹ/ – اہم سنگ میل عبور کرنے کے ساتھ ہی امریکہ کی بلڈ کوایگولیشن مارکیٹ میں سوئس ادارے کا داخلہ دنیا کے بڑے پلازما مصنوعات بنانے والے اداروں میں سے ایک اوکٹافارما اے جی نے آج اعلان کیا ہے کہ اس نے امریکی فوڈ اینڈ ڈرگ …
Read More »Octapharma Receivesreceives Orphan Drug DesignationExclusivity Approval for wilate(R) – the First Replacement Therapy Developed Specifically for von Willebrand Disease
LACHEN, Switzerland, Jan. 13 / PRNewswire-AsiaNet/ — HOLD UNTIL 13/01/2010 09:00 SYDNEY TIME – Milestone Marks Swiss Company’s Entrance into the U.S. Blood Coagulation Market Octapharma AG, one of the largest plasma products manufacturers in the world, today announced that it has received orphan designation for wilate(R) from the U.S. …
Read More »